CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation PRINCETON, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...